dc.contributor.author |
Khoury N. |
dc.contributor.author |
El-Hayek S. |
dc.contributor.author |
Tarras O. |
dc.contributor.author |
El-Sabban M. |
dc.contributor.author |
El-Sibai M. |
dc.contributor.author |
Rizk S. |
dc.contributor.editor |
|
dc.date |
2014 |
dc.date.accessioned |
2017-09-07T07:00:03Z |
dc.date.available |
2017-09-07T07:00:03Z |
dc.date.issued |
2014 |
dc.identifier |
10.3892/ijo.2014.2635 |
dc.identifier.isbn |
|
dc.identifier.issn |
10196439 |
dc.identifier.uri |
http://hdl.handle.net/10938/11247 |
dc.description.abstract |
Kefir, a fermented milk product, exhibits anti-tumoral activity in vivo; yet its mechanism of action remains elusive. Recent studies have focused on the mechanism of action of kefir on cancer cells in vitro. The current study aims at examining the effect of kefir on cell survival, proliferation, and motility of colorectal cancer (CRC ) cells. Kefir's anti-cancer potential was tested on CRC cell lines, Caco-2 and HT- 29, through cytotoxicity, proliferation, and apoptotic assays. The expression of certain genes involved in proliferation and apoptosis was measured using reverse transcriptase-polymerase chain reaction (RT- PCR ) and western blotting. To assess the effect of kefir on cancer metastasis, wound-healing and time-lapse movies, in addition to collagen-based invasion assay, were used. The results show that cell-free fractions of kefir exhibit an anti-proliferative effect on Caco-2 and HT- 29 cells. Analysis of DNA content by flow cytometry revealed the ability of kefir to induce cell cycle arrest at the G1 phase. Kefir was also found to induce apoptosis, as seen by cell death ELI SA. Results from RT- PCR showed that kefir decreases the expression of transforming growth factor a (TGF-a); a nd t ransforming g rowth factor-β1 (TGF-β1) in HT- 29 cells. Western blotting results revealed an upregulation in Bax:Bcl-2 ratio, confirming the pro-apoptotic effect of kefir, and an increase in p53 independent-p21 expression upon kefir treatment. MMP expression was not altered by kefir treatment. Furthermore, results from time-lapse motility movies, wound-healing, and invasion assays showed no effect on the motility of colorectal as well as breast (MCF-7 and MB-MDA-231) cancer cells upon kefir treatment. Our data suggest that kefir is able to inhibit the proliferation and induce apoptosis in HT- 29 and Caco-2 CRC cells, yet it does not exhibit a significant effect on the motility and invasion of these cells in vitro. |
dc.format.extent |
|
dc.format.extent |
Pages: (2117-2127) |
dc.language |
English |
dc.publisher |
Spandidos Publications; ATHENS |
dc.relation.ispartof |
Publication Name: International Journal of Oncology; Publication Year: 2014; Volume: 45; no. 5; Pages: (2117-2127); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Kefir exhibits anti-proliferative and pro-apoptotic effects on colon adenocarcinoma cells with no significant effects on cell migration and invasion |
dc.type |
Article |
dc.contributor.affiliation |
Khoury, N., Department of Natural Sciences, Lebanese American University, P.O. Box 13-5053Chouran, Beirut, Lebanon |
dc.contributor.affiliation |
El-Hayek, S., Department of Natural Sciences, Lebanese American University, P.O. Box 13-5053Chouran, Beirut, Lebanon |
dc.contributor.affiliation |
Tarras, O., Department of Natural Sciences, Lebanese American University, P.O. Box 13-5053Chouran, Beirut, Lebanon |
dc.contributor.affiliation |
El-Sabban, M., Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of BeirutBeirut, Lebanon |
dc.contributor.affiliation |
El-Sibai, M., Department of Natural Sciences, Lebanese American University, P.O. Box 13-5053Chouran, Beirut, Lebanon |
dc.contributor.affiliation |
Rizk, S., Department of Natural Sciences, Lebanese American University, P.O. Box 13-5053Chouran, Beirut, Lebanon |
dc.contributor.authorAddress |
Rizk, S.; Department of Natural Sciences, Lebanese American University, P.O. Box 13-5053, Lebanon |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Anatomy, Cell Biology and Physiological Sciences; |
dc.contributor.authorDepartment |
Anatomy, Cell Biology and Physiological Sciences |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
sandra.rizk@lau.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Khoury, N |
dc.contributor.authorInitials |
El-Hayek, S |
dc.contributor.authorInitials |
Tarras, O |
dc.contributor.authorInitials |
El-Sabban, M |
dc.contributor.authorInitials |
El-Sibai, M |
dc.contributor.authorInitials |
Rizk, S |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Rizk, S (reprint author), Lebanese Amer Univ, Dept Nat Sci, POB 13-5053, Beirut 11022801, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Adriana P, 2008, AGRIC, V65, P329; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038-nrd3810; ANGULO L, 1993, J DAIRY RES, V60, P263; Arteaga C, 2003, SEMIN ONCOL, V30, P3, DOI 10.1016-S0093-7754(03)00185-4; Chen CJ, 2007, J MED FOOD, V10, P416, DOI 10.1089-jmf.2006.236; Farnworth E. R., 2005, Food Science and Technology Bulletin: Functional Foods, V2, P1, DOI 10.1616-1476-2137.13938; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038-nrc1098; Furukawa N., 1990, Journal of Japanese Society of Nutrition and Food Science [Nihon Eiyo Shokuryo Gakkai-shi], V43, P450; Furukawa N., 2000, Journal of Agricultural Science Tokyo, V45, P62; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1016-1593-neo.04640; HAMILTON SR, 1993, GASTROENTEROLOGY, V105, P3; Hassan MSU, 2010, ONCOL REP, V24, P1121, DOI 10.3892-or_00000963; Hertzler SR, 2003, J AM DIET ASSOC, V103, P582, DOI 10.1053-jada.2003.50111; HOFF G, 1986, SCAND J GASTROENTERO, V21, P853, DOI 10.3109-00365528609011130; HOLTING T, 1995, EUR J ENDOCRINOL, V132, P229; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073-pnas.0510284103; KUBO M, 1992, YAKUGAKU ZASSHI, V112, P489; LIU C, 1990, BRIT J CANCER, V62, P425, DOI 10.1038-bjc.1990.311; Liu JR, 2006, BRIT J NUTR, V95, P939, DOI 10.1079-BJN20061752; Liu JR, 2002, NUTR CANCER, V44, P182, DOI 10.1207-S15327914NC4402_10; Lopitz-Otsoa Fernando, 2006, Revista Iberoamericana de Micologia, V23, P67; Maalouf Katia, 2011, Cancer Manag Res, V3, P39, DOI 10.2147-CMR.S15109; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038-nrm3434; Messersmith WA, 2007, CLIN CANCER RES, V13, P4664, DOI 10.1158-1078-0432.CCR-07-0065; Morris JC, 2008, J CLIN ONCOL S15, V26, pS9028; MUROFUSHI M, 1986, IMMUNOPHARMACOLOGY, V12, P29, DOI 10.1016-0162-3109(86)90049-4; MUROFUSHI M, 1983, JPN J MED SCI BIOL, V36, P49; Palmer TD, 2011, ADV DRUG DELIVER REV, V63, P568, DOI 10.1016-j.addr.2011.04.008; Preidis GA, 2011, GASTROENTEROLOGY, V140, P8, DOI 10.1053-j.gastro.2010.11.010; Ramesh S, 2009, CELL CYCLE, V8, P11, DOI 10.4161-cc.8.1.7291; Rizk S, 2009, CLIN LYMPHOMA MYELOM, V9, pS198, DOI 10.3816-CLM.2009.s.012; Rodrigues KL, 2005, INT J ANTIMICROB AG, V25, P404, DOI 10.1016-j.ijantimicag.2004.09.020; Rodriguez-Bigas MA, 2003, HOLLAND FREI CANC ME, V2; Sasaki T, 2008, AM J PATHOL, V173, P205, DOI 10.2353-ajpath.2008.071147; SHIOMI M, 1982, JPN J MED SCI BIOL, V35, P75; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322-caac.21166; Simova E, 2006, INT J FOOD MICROBIOL, V107, P112, DOI 10.1016-j.ijfoodmicro.2005.08.020; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016-j.cell.2009.11.007; Ueda Masatsugu, 1998, Invasion and Metastasis, V18, P176, DOI 10.1159-000024510; Vinderola G, 2006, CYTOKINE, V36, P254, DOI 10.1016-j.cyto.2007.01.003; Wolpin BM, 2008, GASTROENTEROLOGY, V134, P1296, DOI 10.1053-j.gastro.2008.02.098; Xiong B, 2002, WORLD J GASTROENTERO, V8, P674 |
dc.description.citedCount |
|
dc.description.citedTotWOSCount |
0 |
dc.description.citedWOSCount |
0 |
dc.format.extentCount |
11 |
dc.identifier.articleNo |
|
dc.identifier.coden |
IJONE |
dc.identifier.pubmedID |
|
dc.identifier.scopusID |
84907212867 |
dc.identifier.url |
|
dc.publisher.address |
POB 18179, ATHENS, 116 10, GREECE |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Int. J. Oncol. |
dc.relation.ispartOfIssue |
5 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
International Journal of Oncology |
dc.relation.ispartofPubTitleAbbr |
Int. J. Oncol. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
45 |
dc.source.ID |
WOS:000342713900038 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Apoptosis |
dc.subject.otherAuthKeyword |
Cell invasion |
dc.subject.otherAuthKeyword |
Cell motility |
dc.subject.otherAuthKeyword |
Colorectal cancer |
dc.subject.otherAuthKeyword |
Kefir |
dc.subject.otherChemCAS |
|
dc.subject.otherIndex |
|
dc.subject.otherKeywordPlus |
GROWTH-FACTOR-ALPHA |
dc.subject.otherKeywordPlus |
ORALLY-ADMINISTERED POLYSACCHARIDE |
dc.subject.otherKeywordPlus |
COLORECTAL-CANCER |
dc.subject.otherKeywordPlus |
ANTITUMOR-ACTIVITY |
dc.subject.otherKeywordPlus |
MILK-KEFIR |
dc.subject.otherKeywordPlus |
IN-VITRO |
dc.subject.otherKeywordPlus |
RECEPTOR |
dc.subject.otherKeywordPlus |
METASTASIS |
dc.subject.otherKeywordPlus |
MICE |
dc.subject.otherKeywordPlus |
KINASE |
dc.subject.otherWOS |
Oncology |